Clinical Trials Logo

Stage IIIA Rectal Cancer AJCC v8 clinical trials

View clinical trials related to Stage IIIA Rectal Cancer AJCC v8.

Filter by:

NCT ID: NCT03592641 Terminated - Clinical trials for Colorectal Carcinoma

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

Start date: July 25, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well savolitinib works in treating patients with MET amplified colorectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). Savolitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT03516942 Active, not recruiting - Clinical trials for Stage III Rectal Cancer AJCC v8

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

Start date: June 11, 2018
Phase:
Study type: Observational

This research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment. Collecting data from patients about their cost and quality of life may help doctors to better understand the impact of cancer treatment on a patient?s employment and finances.

NCT ID: NCT02874885 Active, not recruiting - Clinical trials for Stage III Rectal Cancer AJCC v8

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Start date: September 5, 2013
Phase:
Study type: Observational

This study looks at the level of circulating tumor elements (cancer cells or DNA pieces floating in the blood) and how it may be related to how the tumor responds to standard treatment in patients with rectal cancer that has spread to nearby tissue or lymph nodes (locally advanced). Researchers will also compare the level and genetic characteristics of circulating tumor elements between individuals with rectal cancer and healthy individuals to understand how they may change over time. Information from this study may help researchers better understand rectal cancer.

NCT ID: NCT02107105 Recruiting - Clinical trials for Rectal Adenocarcinoma

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Start date: May 16, 2014
Phase:
Study type: Observational

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.